Andrew Coop, PhD and Chad Johnson, PhD have been issued a U.S. Patent for "Methods of Using Muscarinic Antagonists in the Treatment of Depression."
Andrew Coop, PhD, professor of pharmaceutical sciences and associate dean for students, and Chad Johnson, PhD, assistant professor of pharmaceutical sciences and director of the MS in Medical Cannabis Science and Therapeutics program, have been issued a United States Patent for “Methods of Using Muscarinic Antagonists in the Treatment of Depression.”